LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 53 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $75,224 | +2642.4% | 2,783 | +2091.3% | 0.00% | – |
| Q1 2024 | $2,743 | -72.5% | 127 | -92.3% | 0.00% | – |
| Q4 2023 | $9,986 | -58.2% | 1,656 | -61.4% | 0.00% | -100.0% |
| Q3 2023 | $23,880 | +524.5% | 4,295 | +724.4% | 0.00% | – |
| Q2 2023 | $3,824 | +31766.7% | 521 | -82.8% | 0.00% | – |
| Q1 2023 | $12 | +33.3% | 3,037 | +8.4% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 2,801 | -15.3% | 0.00% | – |
| Q3 2022 | $13,000 | +30.0% | 3,306 | +5.1% | 0.00% | – |
| Q2 2022 | $10,000 | +900.0% | 3,146 | +1279.8% | 0.00% | – |
| Q1 2022 | $1,000 | -92.3% | 228 | -91.8% | 0.00% | – |
| Q4 2021 | $13,000 | +116.7% | 2,786 | +270.5% | 0.00% | – |
| Q3 2021 | $6,000 | – | 752 | +1878.9% | 0.00% | – |
| Q2 2021 | $0 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 900,000 | $5,427,000 | 0.74% |
| Cormorant Asset Management, LP | 2,353,141 | $14,189,440 | 0.68% |
| Ikarian Capital, LLC | 979,462 | $5,906,156 | 0.55% |
| Parkman Healthcare Partners LLC | 429,892 | $2,592,249 | 0.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $9,409,815 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $6,030,000 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 123,206 | $742,932 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 231,471 | $1,395,770 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 127,048 | $766,099 | 0.03% |
| Point72 Asset Management, L.P. | 825,000 | $4,974,750 | 0.01% |